CTI BioPharma (NASDAQ:CTIC) reported quarterly losses of $(0.38) per share. This is a 90 percent decrease over losses of $(0.20) per share from the same period last year.
Coda Octopus Group Earnings Perspective: Return On Invested Capital
According to Benzinga Pro, during Q3, Coda Octopus Group (NASDAQ:CODA) earned $1.33 million, a 0.54% increase from the preceding quarter. Coda Octopus Group also posted a total of $5.83 million in sales, a 8.45% increase since Q2.
